Summit Therapeutics, Inc. (SMMT)
21.92
+1.09
(+5.23%)
USD |
NASDAQ |
Apr 30, 15:40
Summit Therapeutics Shareholders Equity (Quarterly) : 658.86M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.631B |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Eli Lilly & Co. | 26.54B |
| Merck & Co., Inc. | 52.61B |
| Soleno Therapeutics, Inc. | 450.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 751.18M |
| Total Liabilities (Quarterly) | 92.32M |
| Debt to Equity Ratio | 0.0317 |
| Current Ratio | 9.869 |
| Net Debt Paydown Yield | 0.02% |